News | Szabo-Scandic

Term of the Month: saRNA & Product Knowledge: mRNA Production

Written by Melaina Mirosevic | Aug 13, 2026, 1:48:17 PM

Term of the Month: saRNA
Product Knowledge: mRNA Production

How is mRNA created, from design to production? And why is self-amplifying RNA (saRNA) considered an important future trend in biotechnology? Learn more about modern RNA technologies and innovative solutions from Quantoom Biosciences.

saRNA

saRNA (self-amplifying RNA) is an advancement of traditional mRNA technology.

The key difference: Once inside the cell, saRNA can replicate itself. This allows a smaller initial amount to yield more biologically active RNA.

Advantages of saRNA

  • Lower required dosage

  • Potentially higherprotein expression

  • Promising for vaccines and future therapeutic applications

Researchers therefore view saRNA as a promising platform for the next generation of RNA-based therapies.

mRNA Production:
From Sequence to Application

Messenger RNA (mRNA) is one of the most significant technologies in modern biotechnology. It became widely known primarily through vaccines, but its potential extends far beyond that. Today, mRNA is being researched for therapeutic applications, personalized medicine, and the development of new biological active ingredients.

The success of an RNA-based application depends on several steps:

1. RNA Design

Properties such as stability, efficiency, and protein expression are optimized as early as the sequence development stage.

2. RNA production

Production must be reproducible, scalable, and cost-effective, from the research laboratory through to industrial production.

3. Formulation and Administration

To ensure that RNA safely reaches the target cells, it is often encapsulated in lipid nanoparticles (LNPs), which provide protection and enable efficient transport.

Partner Spotlight:

 

Quantoom Biosciences offers technologies for the entire RNA value chain, from development to production. Its portfolio includes solutions for RNA design, production, and formulation, as well as supporting development and manufacturing services.

This enables research institutions, biotech companies, and manufacturers to implement RNA-based projects more efficiently and quickly.